Results 61 to 70 of about 6,464 (211)

Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole resistant invasive aspergillosis. [PDF]

, 2013
Contains fulltext : 118362.pdf (Publisher’s version ) (Open Access)OBJECTIVES: Azole resistance is an emerging problem in the treatment of Aspergillus fumigatus infections.
Melchers, W.J.G., Seyedmousav, S., Mouton †, J.W., Mouton, J.W., Bruggemann, R.J.M., Verweij, P.E.   +5 more
core   +1 more source

Phenomenon of Dip Effect in Antifungal Susceptibility Testing of Candida tropicalis by using MIC Testing Strips against Echinocandins [PDF]

Journal of Clinical and Diagnostic Research
Minimum Inhibitory Concentration (MIC) of an antifungal is the minimum concentration that completely inhibits the visible growth of fungi under regulated, uniform and consistent in-vitro conditions.
Sujata lall, Vivek Bhat
doaj   +1 more source

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

International Journal of Infectious Diseases, 2020
Introduction: A possible increase in Candida resistance, especially in Candida glabrata, has been speculated according to poor diffusion of echinocandins to peritoneal fluid.
Francesca Gioia, Alicia Gomez-Lopez, Maria Elena Alvarez, Elia Gomez-García de la Pedrosa, Pilar Martín-Davila, Manuel Cuenca-Estrella, Santiago Moreno, Jesús Fortun   +7 more
doaj   +1 more source

Peer review of the pesticide risk assessment of the active substance Trichoderma harzianum T78

EFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, The Netherlands, for the pesticide active substance Trichoderma harzianum T78 and the considerations as regards the inclusion of the substance in Annex IV ...
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Marco Binaglia, Anna Federica Castoldi, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Mark Egsmose, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Oriol Magrans, Iris Mangas, Silvia Mazzega, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Adriana Scattareggia Marchese, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza   +48 more
wiley   +1 more source

Filter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro [PDF]

, 2018
Candidemia is frequent in critically ill patients, especially in combination with an acute kidney injury (AKI). Echinocandins generally are recommended for therapy of such infections.
Kolbinger, Peter
core   +1 more source

Activity of anidulafungin against Candida albicans isolated from clinical specimens

Current Issues in Pharmacy and Medical Sciences, 2009
Infections caused by C. albicans are an important medical problem in people from risk groups, e.g. hospitalized patients. The aim of this paper was to analyse by the E-test procedure, the in vitro activity of anidulafungin against clinical isolates of C.
Anna Biernasiuk, Katarzyna Matuska, Agnieszka Grzegorczyk, Justyna Szymańska, Anna Malm   +4 more
doaj  

Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases

Frontiers in Pharmacology
BackgroundCaspofungin, micafungin, and anidulafungin are three commonly used echinocandins recommended for the treatment of invasive candidiasis. This study aimed to comprehensively evaluate the safety profiles of these three agents to assist clinicians ...
Jingxiu Chen, Chunhua Chen, Xiaobin Lin, Jiajia Yan, Yifan Zheng, Yifan Zheng, Pan Chen, Jia Li, Jia Li   +8 more
doaj   +1 more source

An Update on the Current Practice on the Management of Fungal Necrotizing Otitis Externa: A Systematic Analysis of the Literature

Eye &ENT Research, Volume 3, Issue 2, Page 59-68, June 2026.
ABSTRACT Malignant otitis externa (MOE), necrotizing otitis externa (NOE), or skull base osteomyelitis (SBO) is a severe ear infection, primarily caused by Pseudomonas aeruginosa with 5%–20% of cases due to fungal species. Fungal NOE affects immunocompromised patients.
Mohammed A. Elkrim Saad Mohammed, Syed Zohaib Maroof Hussain, Syed Salman Hashmi, Mehreen Akram, Owais Mattoo, Hassan Nounou, Mohammad Elmorsy, Irfan Khan, Asad Qayyum   +8 more
wiley   +1 more source

Anidulafungin dosing in critically ill patients with continuous venovenous haemodifiltration [PDF]

Background: Anidulafungin is indicated as a first-line treatment for invasive candidiasis in critically ill patients. In the intensive care unit, sepsis is the main cause of acute renal failure, and treatment with continuous renal replacement therapy ...
Aguilar Aguilar, Gerardo, Badenes-Quiles, Rafael, Belda Nacher, Francisco Javier, Navarro Ortega, David   +3 more
core   +1 more source

Clinical Outcomes of Micafungin and Anidulafungin in Candidozyma auris (Formerly Candida auris) Candidemia: A Propensity Score-Matched Retrospective Cohort Study

Journal of Fungi
Candidozyma auris (formerly Candida auris) is a critical-priority multidrug-resistant pathogen. Comparative clinical data on first-line echinocandins—micafungin and anidulafungin—in C. auris candidemia remain limited.
Eyüp Arslan, Ömer Karaşahin, Betül Yüsra Şirin, Deniz Turan, Yıldız Olçar, Umut Elmas, Fatma Yılmaz Karadağ, Derya Öztürk Engin   +7 more
doaj   +1 more source